Zealand Pharma A/S
KV1.3 blockers
Last updated:
Abstract:
The present invention provides novel blockers of the potassium channel Kv1.3, polynucleotides encoding them, and methods of making and using them.
Status:
Grant
Type:
Utility
Filling date:
23 Jun 2021
Issue date:
5 Apr 2022